游离黏膜移植优化垂体术后鞍区重建:首50例连续患者的结果
研究回顾性纳入50例内镜垂体肿瘤手术并采用鼻腔底游离黏膜移植重建鞍区的连续患者,随访3至16个月。术中脑脊液漏检出率为40%,术后无漏;术后1个月移植物完全愈合,供区近完全或完全黏膜化;SNOT-22术前与术后1个月总分无显著差异。作者认为该技术简便安全,鼻腔并发症少。
要点
- 50例连续患者采用鼻腔底游离黏膜移植重建鞍区,术后无脑脊液漏。
- 术中脑脊液漏检出率为40%,未使用脂肪移植或腰大池引流。
- SNOT-22术前与术后1个月总分无显著差异,黏膜取材未加重生活质量负担。
核心结论
- 鼻腔底游离黏膜移植是简便安全的技术,鼻腔并发症少;尽管肿瘤切除积极,术后无脑脊液漏;未使用腰大池引流或脂肪移植;黏膜取材未加重SNOT-22测量的生活质量。
研究设计与样本
- 回顾性分析50例因垂体肿瘤接受内镜手术并以鼻腔底游离黏膜移植重建鞍区的连续患者,术后随访3至16个月。
主要发现
- 术中脑脊液漏检出率为40%,术后无脑脊液漏。
- 术后1个月鼻内镜显示移植物与颅底完全愈合,供区近完全或完全黏膜化。
- SNOT-22术前总分与术后1个月总分无显著差异。
关键数值与推荐
- 术后脑脊液漏发生率在不同系列中为1.9%至10%。
- 采用胶原硬膜移植物内衬、游离黏膜移植物覆盖鞍区缺损,未使用脂肪移植或腰大池引流。
- SNOT-22于术前、术后1个月和3个月进行。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative cerebrospinal fluid leak after endoscopic pituitary surgery ranges from 1.9% to 10% in different series. Vascularized flaps have reduced the incidence of leak; however, this carries nasal morbidity. This study presents a technique for sellar reconstruction with free mucosal graft from the nasal cavity floor including inferior meatus mucosa. This technique aims to standardize sellar reconstruction without the use of the nasoseptal flap and to keep the advantage of mucosal coverage of the defect in all cases. METHODS: Fifty consecutive patients who had endoscopic surgery for pituitary tumors and reconstruction with nasal cavity floor free mucosal graft were retrospectively reviewed. There were a total of 50 patients with postoperative follow-up from 3 to 16 months. Collagen dural graft was used inlay and free mucosal graft overlay to cover the sellar defect. No fat grafts or lumbar drains were used. A Sinonasal Outcome Test-22 (SNOT-22) was performed before, 1 and 3 months after surgery. RESULTS: There were 40% detected intraoperative leaks and no postoperative leaks. Nasal endoscopy performed at 1 month follow-up showed complete healing of the graft to the skull base and near total or complete mucosalization of the donor site. No significant difference was found in the SNOT-22 comparing the total preoperative and 1-month scores. CONCLUSIONS: The nasal cavity floor free mucosal graft is an easy and safe technique, with minimal nasal morbidity. There were no postoperative cerebrospinal fluid leaks, despite aggressive tumor resection. No lumbar drains or fat graft were used. The harvest of mucosal graft does not worsen the quality of life measured with the SNOT-22 test.
引用
- Peris-Celda M, Chaskes M, Lee DD, et al. Optimizing Sellar Reconstruction After Pituitary Surgery with Free Mucosal Graft: Results from the First 50 Consecutive Patients. World Neurosurg. 2017. PMID: 28185972. doi:10.1016/j.wneu.2017.01.102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。